OutSpent
← The Senators

Roll call · H.R. 5376 · 2022

Inflation Reduction Act (drug prices)

Let Medicare negotiate drug prices for the first time. A no vote sided with the pharmaceutical industry.

What happened

The Senate split evenly, 50–50. A tie normally loses, but the Vice President cast the deciding Yea, so it passed by the narrowest possible margin.

The tally

50 Yea · 50 Nay. Officially recorded as “Passed 50-50 (VP tiebreak).”

Party split

Yea: 48 Democrats, 2 Independents. Nay: 50 Republicans.

Crossed party lines

None. Every senator voted with their party.

Official Senate roll call ↗

Who lobbied this bill

6,226 organizations reported lobbying on this bill in 2022. Among them, familiar names from the seven worst industries:

Pharma & HealthAmgen, Bristol Myers Squibb, Cigna, Eli Lilly, Johnson & Johnson, Merck, Novartis, PhRMA, UnitedHealth
DefenseGeneral Dynamics, Lockheed Martin
Big TechMicrosoft

Source: Senate lobbying disclosures (LDA). Filings report spending across many bills at once, so there's no honest per-bill dollar figure. This is who reported working the bill, not how much they spent on it.

A gold dot marks the side that favored concentrated money on this vote. Senators in office today are clickable, so tap any name for their full record. Source: the official Senate roll call, linked above.